How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

About Advanced Micro Devices Inc. Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and ...

AI agents are powerful, but without a strong control plane and hard guardrails, they’re just one bad decision away from chaos.

A marriage of formal methods and LLMs seeks to harness the strengths of both.